4/A//SEC Filing
Ragard John Phillip 4/A
Accession 0002031593-24-000002
CIK 0000926617other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 6:16 PM ET
Size
8.0 KB
Accession
0002031593-24-000002
Insider Transaction Report
Form 4/AAmended
Ragard John Phillip
Director
Transactions
- Exercise/Conversion
Common Stock
2024-09-30+4,844→ 120,203 total - Exercise/Conversion
Restricted Stock Units
2024-09-30−4,844→ 14,531 total→ Common stock (4,844 underlying)
Footnotes (4)
- [F1]Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.
- [F2]Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.
- [F3]On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4.
- [F4]This report is being filed to correct the derivative securities from acquired to disposed.
Documents
Issuer
Aspira Women's Health Inc.
CIK 0000926617
Entity typeother
Related Parties
1- filerCIK 0002031593
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 6:16 PM ET
- Size
- 8.0 KB